A pharmacokinetic and tolerability evaluation of two continuous subcutaneous infusion systems compared to an oral controlled-release morphine

Journal of Pain and Symptom Management

Volumn 19, Issue 5, 2000, Pages 348-356

  Lynch, Pia Mikkelsen ^a   Butler, Jackie ^a   Huerta, Deanne ^a   Tsals, Izrail ^a   Davidson, Diana ^a   Hamm, Sharon ^a  

^a Elan Pharmaceutical Research Corporation   (United States)

Author keywords

Analgesia; Continuous subcutaneous infusion; Morphine sulfate; Pain

Indexed keywords

MORPHINE; MORPHINE SULFATE;

ABDOMINAL PAIN; ADULT; ANALGESIA; AREA UNDER THE CURVE; ARTICLE; CANCER PAIN; CONTROLLED RELEASE FORMULATION; DEVICE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG TOLERANCE; FEMALE; HUMAN; HUMAN EXPERIMENT; INJECTION SITE; MALE; NAUSEA; SOMNOLENCE;

ADMINISTRATION, ORAL; ADULT; ANALGESICS, OPIOID; EQUIPMENT DESIGN; FEMALE; HUMANS; INFUSION PUMPS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; MORPHINE;

EID: 0034086895     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(00)00130-5     Document Type: Article

References (12)

1. Moulin D.E., Kreeft J.H., Murray-Parsons N., Bouquillon A.I. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet. 337:1991;465-467.
2. Lang A.H., Abbrederis K., Dzien A., Drexel H. Treatment of severe cancer pain by continuous infusion of subcutaneous opioids. Recent Results Cancer Res. 121:1991;51-57.
3. Coyle N., Cherny N., Portenoy R. Subcutaneous opioid infusions at home. Oncology. 4:1994;21-31.
4. Lehmann L.J., DeSio J.M., Radvany T., Bikhazi G.B. Transdermal fentanyl in postoperative pain. Reg Anesth. 22:1997;24-28.
5. Dickson R.J., Russell P.S. Continuous subcutaneous analgesics for terminal care at home. Lancet. 1:1982;165.
6. Swanson G., Smith J., Bulich R., New P., Shiffman R. Patient-controlled analgesia for chronic cancer pain in the ambulatory setting. a report of 117 patients J Clin Oncol. 17:1989;1903-1908.
7. Drexel H., Dzien A., Spiegel R.W., Lang A.H., Breier C., Abbrederis K., Patsch J.R., Braunsteiner H. Treatment of severe cancer pain by low-dose continuous subcutaneous morphine. Pain. 36:1989;69-76.
8. Kerr I.G., Sone M., Deangelis C., Iscoe N., MacKenzie R., Schueller T. Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients. Ann Intern Med. 108:1988;554-557.
9. Nelson K., Glare P., Walsh D., Groh E. A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain. J Pain Symptom Manage. 13:1997;262-267.
10. Moulin D., Johnson N., Murray-Parsons N., Geoghegan M., Goodwin V., Chester M. Subcutaneous narcotic infusions for cancer pain. treatment outcome and guidelines for use Can Med Assoc J. 146:1992;891-897.
11. Logan M., Fothergill-Bourbonnais F. Continuous subcutaneous infusion of narcotics. Canadian Nurse. 86:1990;31-32.
12. Shvartzman P., Bonneh D. Local skin irritation in the course of subcutaneous morphine infusion. a challenge J Palliat Care. 10:1994;44-45.